Fluconazole therapy in Candida albicans spondylodiscitis

Citation
P. Rossel et al., Fluconazole therapy in Candida albicans spondylodiscitis, SC J IN DIS, 30(5), 1998, pp. 527-530
Citations number
13
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00365548 → ACNP
Volume
30
Issue
5
Year of publication
1998
Pages
527 - 530
Database
ISI
SICI code
0036-5548(1998)30:5<527:FTICAS>2.0.ZU;2-V
Abstract
A case of Candida albicans spondylodiscitis in a 20-year-old female liver t ransplant recipient is reported, The patient was successfully treated with sequential therapy with liposomal amphotericin B and fluconazole. A review of the literature showed 10 cases of Candida albicans spondylodiscitis succ essfully treated either with fluconazole alone or a sequential therapy with amphotericin B and fluconazole. If long-term amphotericin B therapy is not feasible, a prolonged course of fluconazole in a daily dose of 200-400 mg may be considered as an alternative.